Viewing Study NCT04612894


Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2026-02-09 @ 8:53 AM
Study NCT ID: NCT04612894
Status: UNKNOWN
Last Update Posted: 2020-11-03
First Post: 2020-10-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer
Sponsor: Fudan University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Thyroid Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None thyroid cancer View
None locally advanced View
None neoadjuvant View
None Camrelizumab View
None Apatinib View